“We are pleased that so many pharmaceutical and biotech researchers have participated in the Endpoints to Insights initiative and have raised their voices to make it a truly interactive experience,” said Scott Dixon, Vice President, Marketing at ERT
Philadelphia, PA (PRWEB) December 01, 2015
ERT, the leading cloud platform solutions provider delivering clinical and scientific innovation through its patient-centric data collection and intelligence solutions, today announced the final installments of its 2015 ‘Endpoints to Insights’ Educational initiative. The initiative is designed to provide relevant and practical information to pharmaceutical and biotech researchers.
Each month, the Endpoints to Insights initiative focuses on different aspects of effective endpoint data collection and on-demand analytics for clinical trials and healthcare. The final installments to the 2015 program include the following webinars:
- December 9, 2015: Improving Clinical Outcomes and Medication Adherence with Integrated Medical Devices
- December 10, 2015: Maximize Oncology Trial Subject Recruitment and Help More Patients with Centralized ECG Reading
- December 17, 2015: The Potential of Pulmonary Function as an Outcome Parameter in Non-Respiratory Trials
“We are pleased that so many pharmaceutical and biotech researchers have participated in the Endpoints to Insights initiative and have raised their voices to make it a truly interactive experience,” said Scott Dixon, Vice President, Marketing at ERT. “We look forward to continuing the initiative with more programs to meet their educational needs throughout 2016.”
For additional information and to register for any upcoming webinars, please visit: https://www.ert.com/upcoming-webinars/. Access to recently recorded webinars can be found at https://www.ert.com/past-webinars/.
ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products.
ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., and in Germany, Japan, Switzerland and the U.K.